SCHEMBL10147411

SCHEMBL10147411

CCOC(=O)C(=O)CC(=O)c1ccc(C)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 2/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 2/20 0.49
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
TAS1R3 Q7RTX0 1/20 0.45
TAS1R1 Q7RTX1 1/20 0.45
TAS1R2 Q8TE23 1/20 0.45
HSD11B1 P28845 1/20 0.44
DHODH Q02127 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GAA P10253 1/20 0.42
ERCC5 P28715 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15868169 0.85 ALDH1A1 (0.48) SMN1; SMN2MEN1KMT2AALDH1A1POLB
SCHEMBL11766232 0.84 SMN1; SMN2 (0.53) SMN1; SMN2MEN1KMT2AALDH1A1MAPT
SCHEMBL15869832 0.84 HTT (0.57) SMN1; SMN2MEN1KMT2AALDH1A1POLB
SCHEMBL1739513 0.81 ERCC5 (0.65) SMN1; SMN2MEN1KMT2AALDH1A1POLB
SCHEMBL10147418 0.81 EGLN1 (0.49) SMN1; SMN2MEN1KMT2AALDH1A1MAPT
SCHEMBL2911004 0.80 ALDH1A1 (0.58) SMN1; SMN2MEN1KMT2AALDH1A1POLB
SCHEMBL28455190 0.80 SMN1; SMN2 (0.51) SMN1; SMN2MEN1KMT2AMAPTTAS1R3
SCHEMBL7215600 0.79 SMN1; SMN2 (0.47) SMN1; SMN2MEN1KMT2AALDH1A1POLB
SCHEMBL22062254 0.78 KMT2A (0.49) SMN1; SMN2MEN1KMT2AMAPTNPC1
SCHEMBL16672790 0.78 MEN1 (0.49) SMN1; SMN2MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8993556-B2 Resorcinol derivatives as HSP90 inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2015-03-31 US disclosed
US-20120046266-A1 RESORCINOL DERIVATIVES AS HSP90 INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046266-A1 RESORCINOL DERIVATIVES AS HSP90 INHIBITORS HSP90AB1, HSP90AA1, HSP90AB2P SMN1; SMN2 2228/4885MEN1 3746/4885KMT2A 3186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.